Cynthia Timmers

Cynthia Timmers' work centers on translational and clinical cancer immunology, focusing on biomarkers and pharmacodynamic profiling for immunotherapies such as checkpoint blockade antibodies, bispecific antibodies, and kinase inhibitors. Recent projects span solid tumors (colorectal, ovarian, lung, breast), blood cancers (myelofibrosis, polycythemia vera), and skin conditions like atopic dermatitis and graft-versus-host disease, often using imaging and single-cell/spatial transcriptomic techniques to track immune and tumor responses. Much of this research appears to occur in collaboration with pharmaceutical/clinical trial teams, given the frequent conference abstracts on drug candidates.

Publication output has been relatively steady over the past decade with a large spike in 2023, followed by a return to more typical annual counts.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026